Ligand Pharmaceuticals | GJELD



Debt Endring Dato
Amgen USD 60.1B 299M 2024-12
Arrowhead Research USD 409.41M 16.23M 2024-12
Baxter International USD 13.13B 191M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
Glaxosmithkline GBP 16.99B 927M 2024-12
Insmed USD 1.13B 147.86M 2024-12
Ionis Pharmaceuticals USD 1.25B 32.8M 2024-12
Ligand Pharmaceuticals USD 24K 0 2024-12
MacroGenics USD 0 0 2024-09
Merck USD 37.11B 1.02B 2024-12
Pacira USD 585.32M 2.04M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Veracyte USD 0 100K 2024-12



Ligand Pharmaceuticals GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.